Supernus Pharmaceuticals, Inc. (SUPN)
42.38
+0.20
(+0.47%)
USD |
NASDAQ |
Oct 02, 16:00
42.40
+0.02
(+0.05%)
After-Hours: 20:00
Supernus Pharmaceuticals Market Cap : 2.465B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.465B |
| October 01, 2026 | 2.453B |
| September 30, 2026 | 2.503B |
| September 29, 2026 | 2.557B |
| September 28, 2026 | 2.594B |
| September 25, 2026 | 2.481B |
| September 24, 2026 | 2.518B |
| September 23, 2026 | 2.524B |
| September 22, 2026 | 2.545B |
| September 21, 2026 | 2.488B |
| September 18, 2026 | 2.443B |
| September 17, 2026 | 2.496B |
| September 16, 2026 | 2.407B |
| September 15, 2026 | 2.401B |
| September 14, 2026 | 2.413B |
| September 11, 2026 | 2.422B |
| September 10, 2026 | 2.425B |
| September 09, 2026 | 2.447B |
| September 08, 2026 | 2.468B |
| September 04, 2026 | 2.532B |
| September 03, 2026 | 2.557B |
| September 02, 2026 | 2.561B |
| September 01, 2026 | 2.544B |
| August 31, 2026 | 2.571B |
| August 28, 2026 | 2.544B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.570B |
| August 26, 2026 | 2.610B |
| August 25, 2026 | 2.638B |
| August 24, 2026 | 2.624B |
| August 21, 2026 | 2.667B |
| August 20, 2026 | 2.760B |
| August 19, 2026 | 2.823B |
| August 18, 2026 | 2.852B |
| August 17, 2026 | 2.808B |
| August 14, 2026 | 2.808B |
| August 13, 2026 | 2.742B |
| August 12, 2026 | 2.784B |
| August 11, 2026 | 2.727B |
| August 10, 2026 | 2.738B |
| August 07, 2026 | 2.771B |
| August 06, 2026 | 2.720B |
| August 05, 2026 | 2.728B |
| August 04, 2026 | 2.516B |
| August 03, 2026 | 2.676B |
| July 31, 2026 | 2.596B |
| July 30, 2026 | 2.653B |
| July 29, 2026 | 2.709B |
| July 28, 2026 | 2.770B |
| July 27, 2026 | 2.727B |
| July 24, 2026 | 2.681B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Indivior Pharmaceuticals, Inc. | 4.214B |
| Prestige Consumer Healthcare, Inc. | 2.144B |
| Pfizer Inc. | 158.43B |
| Amphastar Pharmaceuticals, Inc. | 1.082B |
| Bristol Myers Squibb Co. | 124.93B |
Market Cap Related Metrics
| PS Ratio | 2.930 |
| Price to Book Value | 2.390 |
| Price to Free Cash Flow | 129.49 |
| Price | 42.38 |
| Earnings Yield | -4.52% |